Canada: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

The Court Grants An Appeal In Favour Of Psychedelic Assisted Psychotherapy – Toth v. Canada, 2025 FCA 119

A ruling from the Federal Court of Canada has resulted in an appeal of prior government refusals to permit access to psilocybin in connection with psilocybin assisted psychotherapy ("PSAP").

Canada Healthcare

ML

McMillan LLP

Patents And Prior Art: Federal Court Clarifies Standards For Anticipation And Obviousness

The Federal Court's recent decision in Alexion Pharmaceuticals, Inc. v. Amgen Canada Inc. (2025 FC 754) offers important guidance on the use of prior art for anticipation arguments in patent validity.

AB

Aird & Berlis LLP

2025 Mid-year Highlights In Canadian Life Sciences IP And Regulatory Law

In the first half of 2025, the Rx IP Update team reported on a number of developments in Canadian life sciences IP and regulatory law. Below are our top stories.

Canada Healthcare

SB

Smart & Biggar

Important New Procedural Guidelines From The PMPRB

The Patented Medicine Prices Review Board (PMPRB) is a Canadian federal agency that regulates the prices of patented medicines in Canada.

AM

Aird & McBurney LP

Final Guidelines From Canada's PMPRB: The New Era Begins

TL

Torys LLP

The Trademark Four(Mula): Enforcement And Risk Mitigation

OH

Osler, Hoskin & Harcourt LLP

Q&A On Managing Intergenerational Growth In Canadian Agribusiness

Canada Real Estate

BJ

Bennett Jones LLP

July 2025 Rosen Sunshine Newsletter

Canada Government

RS

Rosen Sunshine LLP

Finalized PMPRB Guidelines Published

SB

Smart & Biggar

At Long Last: The New PMPRB Guidelines Are Here

Worldwide Healthcare

F

Fasken

CDA Opens Consultation On Proposed List Of Drugs To Inform Development Of National Formulary

Canada Healthcare

SB

Smart & Biggar

North Of Legal Or South Of Safe? Key Legal And Regulatory Considerations To Substantiate "Made In Canada" Claims

Canada Healthcare

LS

Lenczner Slaght LLP

CDA Opens Public Consultation On Pharmacare National Formulary – Deadline July 18, 2025

Canada Healthcare

F

Fasken

Health Canada's New Draft Guidance For Biosimilar Biologic Drugs

Canada Healthcare

F

Fasken

Implications Of The GENIUS Act On Stablecoins In Canada

Canada Technology

MT

Miller Thomson LLP

The Very Large And Vexing Lawsuit Re: Cannabinoid Hyperemesis Syndrome

Canada Cannabis

HS

Harris Sliwoski

Timing Isn't Everything: Termination Upon Return From A Protected Leave Of Absence

Canada Employment

F

Fasken

Conflit d'intérêts dans l'administration d'une succession : ce que l'affaire Virdi Estate (Re) enseigne aux exécuteurs testamentaires

Canada Litigation

MT

Miller Thomson LLP

How CRA Conducts Net Worth Audits And Enforces Gross Negligence Penalties Against Canadian Taxpayers: Lessons From Mann v. The King And Other Cases

RS

Rotfleisch & Samulovitch P.C.

Health Canada Must Redetermine Exemption Requests For Psilocybin (Magic Mushroom)-Assisted Psychotherapy Training

TheraPsil, a patient advocacy organization, and 73 healthcare practitioners (HCPs) have succeeded in the Federal Court of Appeal (FCA) to overturn the refusal of the Minister of Mental Health...

Canada Healthcare

SB

Smart & Biggar

Pharma, National Security And Tariffs: Where Do We Go From Here?

After the tariff frenzy of the first quarter of this year, we've sailed into the doldrums. Not that the tariffs have gone away, or the threat of new ones has subsided, or there is a solid prospect...

Canada Healthcare

BL

Borden Ladner Gervais LLP

Psychedelic Appeal: FCA Rules That Government Must Explain Policy Change On Psilocybin Access

As science evolves, policies may evolve as well. But when policy changes affect how a decision-maker exercises their discretion, those decision-makers must explain why they are taking a new approach.

Canada Healthcare

TL

Torys LLP

Update On Biosimilars In Canada – June 2025

This article provides an update on developments in the biosimilar space in Canada—regulatory, approvals, pending submissions, litigation, and market access—since our March 2024 update.

Canada Healthcare

SB

Smart & Biggar

Travel Insurance And Alcohol: What Every Canadian Needs To Know

Canada Litigation

Wallace Smith LLP

La nouvelle ébauche de la Ligne directrice de Santé Canada sur les médicaments biologiques biosimilaires

Canada Healthcare

FF

Fasken (French)

Health Canada Consultation On Revised Biosimilar Guidance: No Requirement For Comparative Clinical Efficacy And Safety Trials

Canada Healthcare

SB

Smart & Biggar

Legal Services For Buying Or Selling A Convenience Store In Canada

Canada Commercial

Pacific Legal PC

Biosimilar Update: Health Canada Reconsiders Requirement For Comparative Clinical Trials

Canada Healthcare

MT

McCarthy Tétrault LLP

Health Canada Proposes To Remove Phase III Trial Requirement From Biosimilar Approval Pathway

Canada Healthcare

GW

Gowling WLG

Drug And Alcohol Testing In Canada: SCC Denies Leave To Appeal In Power Workers' Union v. Canada

Canada Employment

BL

Borden Ladner Gervais LLP

Apotex Not Entitled To Damages For Delayed Generic Drug Launch

TS

Tierney Stauffer LLP

CDA Update: New Five-Year Strategic Plan And Position Statement On Using AI In Health Technology Assessments

Canada Healthcare

SB

Smart & Biggar

Sector Snapshot: Private Equity Increasingly Hungry For Food And Beverage Industry Deals

Canada Healthcare

BJ

Bennett Jones LLP

Drug And Alcohol Testing In Canada: SCC Denies Leave To Appeal In Power Workers' Union v. Canada

On May 29, 2025, the Supreme Court of Canada (SCC) dismissed an application for leave to appeal from the decision of the Federal Court of Appeal (FCA) upholding drug and alcohol testing requirements...

Canada Employment

BL

Borden Ladner Gervais LLP

Apotex Not Entitled To Damages For Delayed Generic Drug Launch

The Ontario Court of Appeal's recent decision in Apotex Inc. v. Eli Lilly and Company offers important clarity for pharmaceutical companies engaged in patent litigation under the Patented Medicines (Notice of Compliance) Regulations ("NOC Regulations").

TS

Tierney Stauffer LLP

CDA Update: New Five-Year Strategic Plan And Position Statement On Using AI In Health Technology Assessments

On April 15, 2025, Canada's Drug Agency (CDA) released its new five-year strategic plan, Insight to Impact 2025-2030. Formerly the Canadian Agency for Drugs and Technologies in Health (CADTH), this is the CDA's first strategic plan.

Canada Healthcare

SB

Smart & Biggar

Sector Snapshot: Private Equity Increasingly Hungry For Food And Beverage Industry Deals

Private equity investment in the food and beverage industry continues to steadily increase, driven in part by evolving consumer preferences and a heightened focus on sustainability.

Canada Healthcare

BJ

Bennett Jones LLP

Alexion Awarded Injunction Against Amgen In SOLIRIS Patent Action; Court Considers Anticipation By Incorporation By Reference

SB

Smart & Biggar

Episode 76: Scaling Impact Through Entrepreneurship In Food And Hospitality (Podcast)

Join Heather Barnhouse, Partner in our Edmonton office, as she explores women in leadership and entrepreneurship, and the ecosystem that supports them. In episode 76...

Canada Commercial

D

Dentons

Arbitrator Rejects "Lowest-Cost Generic" Policy For Generic Substitutes In Collective Bargaining Agreement

Can an employer limit drug plan reimbursement to only the lowest-cost generic version of a prescribed medication if the collective bargaining agreement...

Canada Employment

C

Cassels

Court Finds Eculizumab Patent Neither Anticipated Nor Obvious

In the first PMNOC decision of the year, Justice Furlanetto upheld the validity of claims 1 and 2 of Alexion's patent no. 2,645,810 which is directed to the antibody...

AK

Aitken Klee

Landlords May Soon Need To Be On (Top Of) Drugs: Unpacking Ontario's Bill 10

On May 1, 2025, the Ontario Attorney General introduced Bill 10, titled the "Protect Ontario Through Safer Streets and Stronger Communities Act, 2025,". The Bill is intended to enhance public safety.

Canada Real Estate

RA

Robins Appleby LLP

Mandatory Front-of-package Labelling Compliance By 2026 — Are You Prepared?

Canada Healthcare

BL

Borden Ladner Gervais LLP

A Guide To Commercial Patriotism: Understanding 'Made In Canada' And Similar Labels

Canada Anti-trust

AB

Aird & Berlis LLP

5 Key Trends Shaping The Life Sciences Industry (Video)

Canada Healthcare

RS

RSM Canada

Licensing Partnerships In Life Sciences: Emerging And Expected Trends In 2025

Canada Healthcare

GW

Gowling WLG

Instruments médicaux basés sur l'IA — Transformation et réglementation

Canada Healthcare

MT

McCarthy Tétrault LLP

Some Things Last Forever: Government Of Canada Proposes Regulatory Measures For PFAS

Canada Environment

OH

Osler, Hoskin & Harcourt LLP

Health Canada Publishes Guide To The Precision Regulating Authorities Under The Food And Drugs Act

Canada Healthcare

SB

Smart & Biggar

Health Canada Seeks Input On New Draft Guidance For Co-packaged Drug Products

Canada Healthcare

SB

Smart & Biggar

Canada's Drug Agency Releases 2025 Watch List Highlighting AI Technologies In Health Care

Canada Healthcare

SB

Smart & Biggar

Exploring A Canadian Regulatory Framework For Cannabidiol (CBD)

Canada Healthcare

TL

Torys LLP

Episode 19: Advancing Superfood Innovation And Unlocking The Power Of The Haskap Berry (Podcast)

Canada Healthcare

D

Dentons

Trade War Update: Relief For Some As Canada Orders Six-Month Reprieve On Retaliatory Tariffs On A Wide Range Of Imported Goods

Canada International

MT

McCarthy Tétrault LLP

Emergency Medicine: Innovations In Regulations For Public Health Drugs

Canada Healthcare

MT

McCarthy Tétrault LLP

L'influence de l'IA sur le domaine de la santé au Canada

Canada Technology

MT

Miller Thomson LLP

AI's Influence On Shaping The Health Industry In Canada

Canada Healthcare

MT

Miller Thomson LLP

See more

Latest Videos

See more

From Discovery To Market: The Role Of IP Strategy In Drug Development (Video)

GW

Gowling WLG

Drug Pricing And Reimbursement: The Role Of Provinces And Hospitals In Pharmaceutical Pricing (Video)

TL

Torys LLP

Le Secteur De La Santé Au Canada Après La COVID-19 : Perspectives Juridiques, Médicales Et Commerciales (vidéos)

SE

Stikeman Elliott LLP

Cannabis 2.0 Rollout: Edibles, Extracts Legalized (Video)

BC

Blake, Cassels & Graydon LLP

Emerging Growth And Venture Technology Video Series Part Two: Weed Growth (Video)

D

Dentons

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More